CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Qrxpharma Ltd - ADR Company Snapshot
Qrxpharma Ltd - ADR operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Qrxpharma Ltd - ADR with three other miscellaneous service companies in North America: The Jenex Corporation of Canada (2016 sales of 4,793.00 Canadian Dollars [US$3,574.19 ] ), Zynerba Pharmaceuticals Inc ($7,250.00 of which 100% was Pharamceutical), and Bio-Path Holdings, Incorporation. ($13,000.00 of which 100% was Nucleic Acid Drugs).

Sales Analysis. During the year ended June of 2016, sales at Qrxpharma Ltd - ADR were $11,633.28 . This is an increase of 56.2% versus 2015, when the company's sales were $7,447.32 . Despite this increase, sales are still well below the level achieved in 2014, when Qrxpharma Ltd - ADR reported sales of $612,339.80 .
   
   
 
  Stock Performance Chart for Qrxpharma Ltd - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (5/11/2017): .01
(Figures in U.S. Dollars)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
 
Qrxpharma Ltd - ADR Key Data:
  Ticker: QRXPY Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 11,633
(Year Ending Jan 2017).
Employees: N/A
  Currency: U.S. Dollars Market Cap: 197,029
  Fiscal Yr Ends: June Shares Outstanding: 32,838,194
  Share Type: ADR Closely Held Shares: 7,786,081
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.